NEFL and nervous system disorder: Serum NfL mRNA expression was significantly higher in MOGAD patients than control patients with noninflammatory neurological diseases (0.98 ± 1.60 vs. 0.21 ± 0.32, p = 0.031, p < 0.05) (Figure 1A).